Jubilant Life Nanjangud plant closed as some staff found Covid-19 positive

PTI New Delhi | Updated on March 31, 2020 Published on March 31, 2020

Drug firm Jubilant Life Sciences on Tuesday said its Nanjangud plant in Karnataka has been shut until April 10 and all the employees are under self-quarantine after some of its staff tested positive for COVID-19.

On March 26, the district administration of Nanjangud informed the company that one of the employees from the Nanjangud plant has tested positive for Covid-19.

The employee is under medical supervision at a government hospital and is recuperating well, Jubilant Life Sciences said in a filing to the BSE.

“We have been again informed that some more employees from the same plant have also tested positive for Covid-19,” it added.

“The plant, which is part of Jubilant Generics Ltd, a wholly-owned subsidiary of a material subsidiary of the Company, has been temporarily shut down until April 10, 2020 and all the employees are under self-quarantine,” it said.

When contacted, the company did not provide the number of employees who have tested positive.

“Health and safety of our employees as well the nearby community is of utmost importance to us. We have been taking all the necessary precautions like sanitising the buses, temperature checking at the gate, providing sanitisers in all offices and following all the government directed protocols on health and safety,” Jubilant Life Sciences said.

In a statement, the company said the entire plant area is being sanitised again.

“To facilitate the well-being of our employees, we are arranging food and other necessary items. We are also distributing nose mask and soap/sanitiser within the local community and providing all the help and support to the community and to the local administration,” it added.

Published on March 31, 2020

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.